You are here

Paragh György

Paragh György

Paragh György
DE
Medical and Health Science Center
centrumelnök 2007-
DE > ÁOK
1st Department of Internal Medicine
intézetvezető 2012-
Name: Paragh György
Affiliation:
  • Debreceni Egyetem. Általános Orvostudományi Kar. Belgyógyászati Intézet. Anyagcsere Betegségek Nem Önálló Tanszék / University of Debrecen. Faculty of Medicine. Department of Internal Medicine. Division of Metabolism
  • Debreceni Egyetem. Orvos- és Egészségtudományi Centrum / University of Debrecen. Medical and Health Science Center
  • Debreceni Egyetem. Általános Orvostudományi Kar. Belgyógyászati Intézet. I. sz. Belgyógyászati Klinika / University of Debrecen. Faculty of Medicine. Department of Internal Medicine. 1st Department of Internal Medicine
Degree
  • általános orvos (1978)
  • belgyógyász szakorvos (1983)
  • kandidátus, MTA (1988)
  • kardiológus szakorvos (1989)
  • habil (1998)
  • MTA doktora, MTA (2000)
  • endokrinológiai szakorvos (2001)
  • lipidológus szakképesítés (2003)
  • sürgősségi orvostan szakorvos (2007)
  • belgyógyászati angiológia minősített orvosa (2008)
Profession: physician, cardiologist, endocrinologist
A lipidek szerepe a szív- és érrendszeri betegségek megelőzésében - Előadás a Mindentudás Egyetemén (2011. május 18.)

Publication list

Uploaded publications:
837
Publications in DEA:
814
OA:
308
Date range:
1983-2024
2024
  1. Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., Harangi, M.: Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity.
    Int. J. Mol. Sci. 25 (11), 1-12, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  2. Paragh, G., Harangi, M., Bársony, G., Mazzag, B., Együd, F.: Milyen volt a hyperlipidaemia kezelése és a kezelőorvosok attitűdje 2022-ben?.
    Metabolizmus. 22 (1), 26-32, 2024.
  3. Paragh, G., Zilahi, P., Kolozsvári, L., Lőrincz, H., Fülöp, P., Harangi, M.: Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): from Traditional Agents to Future Treatment Options.
    Life (Basel). 14 1-14, 2024.
    Journal metrics:
    Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    Q2 Ecology, Evolution, Behavior and Systematics (2023)
    Q1 Paleontology (2023)
    Q2 Space and Planetary Science (2023)
2023
  1. Pikó, P., Jenei, T., Kósa, Z., Sándor, J., Kovács, N., Seres, I., Paragh, G., Ádány, R.: Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk.
    Int. J. Mol. Sci. 24 (12), 1-16, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  2. Pikó, P., Kósa, Z., Sándor, J., Seres, I., Paragh, G., Ádány, R.: Association of HDL-C subfraction profile with the progression of insulin resistance.
    Atherosclerosis. 379 s60-s61, 2023.
    Journal metrics:
    Q1 Cardiology and Cardiovascular Medicine
  3. Pikó, P., Jenei, T., Kósa, Z., Sándor, J., Kovács, N., Seres, I., Paragh, G., Ádány, R.: Association of HDL Subfraction Profile with the Progression of Insulin Resistance.
    Int. J. Mol. Sci. 24 (17), 1-13, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  4. Lőrincz, H., Somodi, S., Ratku, B., Harangi, M., Paragh, G.: Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity.
    Metabolites. 13 (2), 1-27, 2023.
    Journal metrics:
    Q2 Biochemistry
    Q2 Endocrinology, Diabetes and Metabolism
    Q2 Molecular Biology
  5. Juhász, L., Lőrincz, H., Szentpéteri, A., Tóth, N., Varga, É., Paragh, G., Harangi, M.: Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions.
    Int. J. Mol. Sci. 24 (20), 1-14, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  6. European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration: Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
    Lancet. S0140-6736 (23), 1-12, 2023.
  7. Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Seres, I., Paragh, G., Harangi, M.: Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients.
    Int. J. Mol. Sci. 24 (22), 1-13, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  8. Lőrincz, H., Ratku, B., Csiha, S., Seres, I., Szabó, Z., Paragh, G., Harangi, M., Somodi, S.: Impaired Organokine Regulation in Non-Diabetic Obese Subjects: halfway to the Cardiometabolic Danger Zone.
    Int. J. Mol. Sci. 24 (4), 1-13, 2023.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  9. Rizzo, M., Colletti, A., Penson, P., Katsiki, N., Mikhailidis, D., Tóth, P., Gouni-Berthold, I., Mancini, J., Marais, D., Moriarty, P., Ruscica, M., Sahebkar, A., Vinereanu, D., Cicero, A., Banach, M., International Lipid Expert Panel (ILEP): Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
    Pharmacol. Res. 189 1-8, 2023.
  10. Banach, M., Lewek, J., Pol, K., Rabczenko, D., Balanescu, S., Blaha, V., Ceska, R., Jankowski, P., Surma, S., Kolovou, G., Liberopoulos, E., Mitu, F., Mitu, M., Naji, F., Paragh, G., Popawska, M., Vrablík, M., Pella, D.: Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study.
    Front. Cardiovasc. Med. 10 1-9, 2023.
    Journal metrics:
    Q2 Cardiology and Cardiovascular Medicine
2022
  1. Juhász, I., Ujfalusi, S., Seres, I., Lőrincz, H., Varga, V., Paragh, G., Somodi, S., Harangi, M., Paragh, G.: Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.
    Biomolecules. 12 (1), 1-11, 2022.
    Journal metrics:
    Q1 Biochemistry
    Q2 Molecular Biology